biomedicina slovenica


"Medical Oncology" : 353

  1. Illini Oliver; Fabikan Hannah; Swalduz Aurélie; Vikström Anders; Krenbek Dagmar; Schumacher Michael; Dudnik Elizabeth; Studnicka Michael; Öhman Ronny; Wurm Robert; Čufer Tanja; Mohorčič Katja; Hochmair Maximilian J
    Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP)
    2022
  2. Adam Roman; Tibau Martorell Ariadna; Molto Valiente Consolación; Šeruga Boštjan; Ocaña Alberto; Amir Eitan; Templeton Arnoud J.
    Clinical benefit of cancer drugs approved in Switzerland 2010‐2019
    2022
  3. Casali P. G.; Abecassis N.; Biagini R.; Bielack Stefan; Bonvalot S.; Boukovinas I.; Bovée Judith VMG; Brodowicz Thomas; Frezza A. M.; Unk Mojca
    Gastrointestinal stromal tumours
    2022
  4. Strauss Sandra J.; Frezza A. M.; Abecassis N.; Bajpai Jaya; Bauer Simone; Biagini R.; Bielack Stefan; Boukovinas I.; Bovée Judith VMG; Unk Mojca
    Bone sarcomas
    2021
  5. Huang Lei; Jansen Lina; Verhoeven Rob; Ruurda Jelle P.; Van Eycken Liesbeth; De Schutter Harlinde; Johansson Jan; Lindblad Mats; Zadnik Vesna; Žagar Tina
    Largely varying patterns and trends of primary cancer-directed resection for gastric carcinoma with synchronous distant metastasis in Europe and the US
    2021
  6. Gronchi A.; Abecassis N.; Biagini R.; Bielack Stefan; Bonvalot S.; Boukovinas I.; Bovée Judith VMG; Brodowicz Thomas; Casali P. G.; Unk Mojca
    Soft tissue and visceral sarcomas
    2021
  7. Addeo Alfredo; Hochmair Maximilian J; Janžič Urška; Dudnik Elizabeth; Charpidou Andriani; Płużański Adam; Ciuleanu Tudor; Shterev Donev Ivan; Elbaz Judith; Aar J; Ott René; Peled Nir
    Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC
    2021
  8. Illini Oliver; Hochmair Maximilian J; Fabikan Hannah; Weinlinger Christoph; Tufman Amanda; Swalduz Aurélie; Lamberg Kristina; Hashemi Sayed M. S.; Huemer Florian; Vikström Anders; Mohorčič Katja
    Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN)
    2021
  9. Lukanovič David; Herzog Maruša; Kobal Borut; Černe Katarina
    The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer
    2020
  10. Kamposioras Konstantinos; Mauri Davide; Papadimitriou Konstatinos; Anthoney Alan; Hindi Nadia; Petricevic Branka; Dambrosio Mario; Valachis Antonis; Kountourakis Pantelis; Grašič-Kuhar Cvetka
    Synthesis of recommendations from 25 countries and 31 oncology societies
    2020
  11. Zwakman Marieke; Delden Johannes JM van; Caswell Glenys; Deliens Luc; Ingravallo F.; Jabbarian Lea J.; Johnsen Anna Thit; Korfage Ida Joanna; Mimič Alenka; M C.; Lunder Urška; Červ Branka; Simonič Anja; Kodba Čeh Hana; Ozbič Polona
    Content analysis of Advance Directives completed by patients with advanced cancer as part of an Advance Care Planning intervention
    2020
  12. Gaiser Maria R.; Lorenzen Sylvie; Merx Kirsten; Trojan Jörg; Ocvirk Janja; Ettrich Thomas J.; Al-Batran Salah Eddin; Schulz Holger; Feustel Hans-Peter; Hofheinz Ralf-Dieter
    Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women
    2018
  13. ESMO open
    2016
  14. Journal of Radiotherapy & Medical Oncology
    2008
  15. Boltežar Lučka; Poglajen Gregor
    Srčno popuščanje in onkološko zdravljenje
    [Heart failure and oncologic treatment]
    2020
  16. Lukanovič David; Herzog Maruša; Kobal Borut; Černe Katarina
    The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer
    2020
  17. Pakiž Maja; Matkovič Lonzarič Nives; Krebs Bojan; Dobnik Sarah; Sobočan Monika; Zadravec Kristina
    Experience involving the implementation and compliance with ERAS at a small gynecologic oncology centre
    [Izkušnje z uvajanjem in skladnostjo delovanja z ERAS protokolom v majhnem ginekološkem onkološkem centru]
    2020
  18. Čufer Tanja; Ciuleanu Tudor; Berzinec Peter; Galffy Gabriela; Jakopović Marko; Jassem Jacek; Jovanovic Dragana; MIhaylova Zhasmina; Ostoros Gyula; Thallinger Christiane; Zemanova Milada; Zielinski Christoph
    Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe
    2020
  19. Therapeutic advances in medical oncology
    2009
  20. Salihagić Aida; Jugović Domagoj; Kušan Marija; Landeka Hrvoje; Andreis Igor
    The chronic administration of ion exchange inhibitors markedly suppress tumour growth in vivo
    1998
  21. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
    2020
  22. Šeruga Boštjan; Sullivan Richard; Fundytus Adam; Hopman Wilma M.; Ocaña Alberto; Bodoky Gyorgy; Vanderpuye Verna; Lopes Gilberto; Hammad Nour; Sengar Manju
    Medical oncology workload in Europe
    2020
  23. Mountzios Giannis; Remon J.; Novello Silvia; Blais N.; Califano R.; Čufer Tanja; Dingemans Anne-Marie C.; Liu S. V.; Peled N.; Pennell N. A.
    Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of >= 1 by the USA Food and Drug Administration
    2019
  24. Zwakman Marieke; Pollock K.; Bulli Francesco; Caswell Glenys; Červ Branka; Delden Johannes JM van; Deliens Luc; Heide Agnes van der; Jabbarian Lea J.; Kodba Čeh Hana; Lunder Urška; Simonič Anja; Mimič Alenka; Ozbič Polona
    Trained facilitators' experiences with structured advance care planning conversations in oncology
    2019
  25. Pakiž Maja; Lukman Lara; Kozar Nejc
    Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer
    2019
  26. Vanderpuye Verna; Hammad Nazik; Martei Yehoda; Hopman Wilma M.; Fundytus Adam; Sullivan Richard; Šeruga Boštjan; Lopes Gilberto; Sengar Manju; Brundage Michael D.
    Cancer care workforce in Africa
    2019
  27. Velenik Vaneja; Boc Nina; Ocvirk Janja; Brecelj Erik; Krebs Bojan; Anderluh Franc; Jeromen Ana; Oblak Irena; Šečerov Ermenc Ajra; But-Hadžić Jasna
    Total neoadjuvant treatment of "ugly" rectal cancers in Slovenia
    2019
  28. European Journal of Cancer Care
    1991
  29. Raphael Michael J.; Fundytus Adam; Hopman Wilma M.; Vanderpuye Verna; Šeruga Boštjan; Lopes Gilberto; Hammad Nour; Sengar Manju; Brundage Michael D.; Sullivan Richard; Booth Christopher M.
    Medical oncology job satisfaction
    2019
  30. Casali P. G.; Abecassis N.; Biagini R.; Bielack Stefan; Bonvalot S.; Boukovinas I.; Bovée Judith VMG; Brodowicz Thomas; Broto J. M.; Unk Mojca
    Soft tissue and visceral sarcomas
    2018
  31. Schöffski Patrick; Wozniak Agniezska; Aamdal Steinar; Leahy M. G.; Rutkowski Piotr; Bauer Sebastian; Lindner Lars H.; Zakotnik Branko; Anthoney Alan; Sufliarsky Jozef
    Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3
    2018
  32. Gortnar Tjaša; Grašič-Kuhar Cvetka; Drmota Eva; Kovač Timotej; Kukar Matjaž
    Development of mPRO Mamma mobile application and its impact on the quality of life and health resource usage in patients with early stage and locally advanced breast cancer receiving chemotherapy
    2018
  33. Velenik Vaneja; Omejc Mirko; Ocvirk Janja; Edhemović Ibrahim; Anderluh Franc; Oblak Irena; But-Hadžić Jasna
    Long term efficacy results from the phase II CRAB trial
    2018
  34. Casali P. G.; Bielack Stefan; Abecassis N.; Aro Hannu T.; Bauer Simone; Biagini R.; Bonvalot S.; Boukovinas I.; Bovée Judith VMG; Unk Mojca
    Bone sarcomas
    2018
  35. Fundytus A.; Hopman Wilma M.; Hammad Nour; Biagi J. J.; Sullivan Richard; Vanderpuye V.; Šeruga Boštjan; Lopes Gilberto; Sengar M.; Brundage Michael D.; Booth C. M.
    Medical oncology workload in Canada
    2018
  36. Casali P. G.; Abecassis N.; Biagini R.; Bielack Stefan; Bonvalot S.; Boukovinas I.; Bovée Judith VMG; Brodowicz Thomas; Broto J. M.; Unk Mojca
    Gastrointestinal stromal tumours
    2018
  37. Hofheinz Ralf-Dieter; Lorenzen Sylvie; Trojan Jörg; Ocvirk Janja; Ettrich Thomas J.; Al-Batran Salah Eddin; Schulz Holger; Homann Nils; Feustel H. P.; Schatz Marlene
    EVITA
    2018
  38. Gennari Alessandra; Sun Z.; Hasler-Strub U.; Colleoni Marco; Moos Roger von; Cortes Jorge; Walshe J.; Ribi K.; Bernhard Jürg; Borštnar Simona
    A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer
    2018
  39. Ebert Moltara Maja
    The time frame of palliative care referrals
    2016
  40. Fundytus A.; Sullivan Richard; Vanderpuye V.; Šeruga Boštjan; Lopes Gilberto; Hammad Nour; Sengar M.; Hopman Wilma M.; Brundage Michael D.; Booth C. M.
    Delivery of global cancer care
    2018
  41. Peters Solange; Unk Mojca
    Activity of afatinib in heavily pretreated patients (pts) with HER2 mutation-positive (HER2m1) advanced non-small cell lung cancer (NSCLC)
    2017
  42. Kandolf Sekulović Lidija; Peris Ketty; Hauschild Axel; Stratigos A.; Grob J. J.; Nathan Paul D.; Dummer R.; Forsea A.-M.; Hoeller C.; Ocvirk Janja
    More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
    2017
  43. Bonnefoi Herve; Jacot W.; Saghatchian M.; Moldovan C.; Venat-Bouvet L.; Zaman Khurshid; Matos Erika; Petit T.; Bodmer A.; Quenel-Tueux N.; Chakiba C.
    Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer
    2015
  44. Poston Graeme J.; Wyld Lynda; Audisio Riccardo A.
    Surgical oncology
    2016
  45. Novello S.; Barlesi F.; Califano R.; Čufer Tanja; Ekman S.; Giaj-Levra Piero; Kerr K.; Popat Sanjay; Reck M.; Senan S.
    Metastatic non-small-cell lung cancer
    2016
  46. Turk Zmago
    Specifičnosti rehabilitacije karcinomskih bolnikov
    2008
  47. Tiskovna konferenca ob tednu boja proti bolečini
    2008
  48. Serša Gregor; Kovač Viljem
    Progress of Radiology and oncology
    2010
  49. Karcinomska bol
    2009
  50. Book of abstracts
    2008
  51. Grašič-Kuhar Cvetka; Zakotnik Branko
    Risk factors for relapse free and overall survival in the second decade after surgery in patients with early breast cancer not receiving adjuvant hormonal therapy
    2007
  52. Matos Erika; Škrbinc Breda; Stanovnik Marjeta; Jereb Berta; Zakotnik Branko
    Fertility in patients treated for testicular cancer
    2006
  53. Pajk Bojana
    AJCC cancer staging handbook plus EZTNM
    2005
  54. Zakotnik Branko
    Novosti v sistemskem zdravljenju pljučnega raka
    2007
  55. Ocvirk Janja
    Novosti v zdravljenju tumorjev prebavil
    2007
  56. Pajk Bojana
    Novosti v sistemskem zdravljenju raka dojk
    2007
  57. 3. hrvatski onkološki kongres [i] 13. simpozij Onkološko-hematološkog društva Hrvatske udruge medicinskih sestara [i] 2. onkološki simpozij inženjera medicinske radiologije, Zagreb, 15.-18. ožujak 2006
    2006
  58. Krčevski-Škvarč Nevenka
    Ocena bolečine in izbira zdravljenja bolečine pri onkološkem bolniku
    2008
  59. Bernot Marjana; Pušnik Danijela; Umičević Snežana; Mlakar-Mastnak Denis; Jošt Jožica
    Zaščita medicinskih sester in zdravstvenih tehnikov pri ravnanju s citostatiki in z biološkimi zdravili v slovenskem prostoru
    2008
  60. Novaković Srdjan
    Onkologija
    2009
  61. Schrijvers Dirk; Senn Hansjörg; Mellstedt Håkan; Zakotnik Branko
    ESMO handbook of cancer prevention
    2008
  62. Niraula Saroj; Amir Eitan; Vera-Badillo Francisco Emilio; Šeruga Boštjan; Ocaña Alberto; Tannock Ian
    Risk of incremental toxicities and associated costs of new anticancer drugs
    2014
  63. Al Hashem Hashem Yashem; Al-Mubarak Mustafa; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Amir Eitan
    Impact of geographic region on benefit of anticancer agents evaluated in international phase III clinical trials
    2014
  64. Templeton Arnoud J.; Šeruga Boštjan
    Primum non nocere
    2015
  65. Tibau B.; Bedard Philippe L.; Vera-Badillo Francisco Emilio; Templeton Arnoud J.; Ocaña Alberto; Šeruga Boštjan; Barnadas Agustí; Amir Eitan
    Author financial conflicts of interest (FCOIs) in clinical practice guidelines (CPGs) for systemic anti-cancer drugs
    2014
  66. Oblak Irena; Anderluh Franc; Velenik Vaneja; But Hadžić Jasna; Šečerov Ermenc Ajra; Jeromen Andrej
    Impact of anemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
    2015
  67. Gourgou-Bourgade Sophie; Čufer Tanja
    Guidelines for time-to-event end point definitions in breast cancer trials
    2015
  68. Pušnik Danijela
    Pogovor o težavah s spolnostjo pri pacientih z onkološkim obolenjem - kako pomagati pacientom
    2011
  69. Bonnefoi Herve; Čufer Tanja
    Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes
    2014
  70. Verhoeven R. H. A.; Primic-Žakelj Maja
    Testicular cancer in Europe and the USA
    2013
  71. Velenik Vaneja; Ocvirk Janja; Oblak Irena; Anderluh Franc
    Five-year results of the XERT phase II trial
    2014
  72. Matos Erika; Jug Borut; Zakotnik Branko
    Optimizing adherence to adjuvant trastuzumab therapy
    2014
  73. Oblak Irena; Anderluh Franc; Velenik Vaneja; But Hadžić Jasna; Šečerov Ermenc Ajra; Jeromen Ana; Ratoša Ivica
    Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction (GEJ) cancer and unresectable locally advanced gastric cancer
    2014
  74. Vrankar Martina; Zwitter Matjaž; Kovač Viljem
    Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer
    2014
  75. Oncology meeting resources
    2014
  76. Serša Gregor; Kovač Viljem
    Editorial - progress of Radiology and oncology
    2011
  77. Strojan Primož
    Trditev prof. Janeza Žgajnarja ne drži
    2011
  78. Žgajnar Janez; Hostnik-Šetinc Majda
    Janez Žgajnar
    2011
  79. Rare tumors
    2010
  80. Hočevar Marko
    ECCO oncovideos
    2011
  81. Knavs Nina; Žgajnar Janez; Žličar Anica; Brecelj Erik; Mazej Kukovič Zofija
    Legionela znova pesti Onkološki inštitut
    2008
  82. Hočevar Marko; Jezeršek Novaković Barbara; Novaković Srdjan; Strojan Primož; Žgajnar Janez
    Aroganca ali pomanjkanje empatije
    2008
  83. Auersperg Marija
    Vse oči so uprte v Onkološki inštitut, a večino bolnikov z rakom zdravijo drugje
    2008
  84. Oblak Irena
    Prof. Rades je postal častni član Združenja za radioterapijo in onkologijo SZD
    2012
  85. Reberšek Martina; Boc Marko; Hlebanja Zvezdana; Volk Neva; Benedik Jernej; Ebert Moltara Maja; Mesti Tanja; Ocvirk Janja
    Influence of BRAF V600E and different KRAS mutations on outcome of metastatic colorectal cancer patients treated with first-line therapy
    2012
  86. Oblak Irena; Jeromen Ana; Anderluh Franc; Velenik Vaneja; Skoblar Vidmar Marija; Ratoša Ivica
    Postoperative radiochemotherapy for adenocarcinomas of the gastroesophageal junction
    2012
  87. Velenik Vaneja; Ocvirk Janja; Marolt-Mušič Maja; Bračko Matej; Anderluh Franc; Oblak Irena; Edhemović Ibrahim; Brecelj Erik; Kropivnik Mateja; Omejc Mirko
    Prospective trial of synchronous capecitabine, radiotherapy and bevacizumab for locally advanced rectal cancer (CRAB)
    2012
  88. Esmo
    2012
  89. Adamič Metka; Miholič Mojca; Ocvirk Janja; Ðokić Zdenka
    Boginje v belem
    2008
  90. Žgajnar Janez; Kukovič Urška
    Brez sekundarnih centrov kmalu nesprejemljive čakalne dobe
    2010
  91. Matos Erika
    ESMO 2012
    2012
  92. Zakotnik Branko; Vegelj-Pirc Marija; Vivod Zor Mojca
    Obvladovanje raka ali Kako do čudežnega zdravila
    2011
  93. Borštnar Simona
    Poročilo s kongresa ESMO
    2010
  94. Reberšek Martina
    Poročilo s kongresa ASCO
    2010
  95. Novaković Srdjan
    Ob izidu učbenika Onkologija
    2009
  96. Grašič-Kuhar Cvetka
    Poročilo o 6. srednjeevropskem onkološkem kongresu (CEOC)
    2009
  97. Rotovnik-Kozjek Nada
    1. simpozij ESMO o raku in prehrani
    2009
  98. Rudolf Zvonimir; Strojan Primož; Casar Božidar
    Razpisi pisani na kožo dvema proizvajalcema
    2004
  99. Strojan Primož; Praprotnik Mihaela
    Težo napak nosijo bolniki
    2005
  100. Strojan Primož
    Posodobitev onkologije
    2002

1 101 201 301  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics